1
0
0
News
Antidote Might Reverse Complication From Blood Newsday
www.newsday.com
— ... study," said the study's lead author, Stephan Glund, a researcher with Boehringer Ingelheim, the drug company that makes Pradaxa. › health
Pradaxa antidote works fast, completely in small trial | Reuters
www.reuters.com
An experimental antidote to the widely used blood clot preventer Pradaxa worked immediately and completely in an early-stage trial among healthy volunteers,...
Antidote Might Reverse Complication From Blood Thinner Pradaxa |...
health.usnews.com
... clinical study," said the study's lead author, Stephan Glund, a researcher with Boehringer Ingelheim, the drug company that makes Pradaxa.
Antidote Might Reverse Complication From Blood Thinner Pradaxa
consumer.healthday.com
In early tests, new drug allowed blood to clot again with no apparent side effects
Netzwerk-Profile
LinkedIn: Stephan Glund – Head of Clinical Pharmacology CREAlinkedin.com
› stephan-glund-a
Twitter Profil: #eufemed Twitter Search / Twitter
Niche Science & Tech · @niche_science. ·. May 15, Biologicals are not just “big chemicals” - key learnings from Stephan Glund at #eufemed Image. › hashtag
Interessen
New Data Show Idarucizumab* Reverses Anticoagulant Effects of...
www.prnewswire.com
... healthy volunteers, showing that idarucizumab reversed the anticoagulant effects of dabigatran," said lead investigator Stephan Glund, PhD, ...
American Journal of Medicine, The - Vol n° 11S - EM consulte
www.em-consulte.com
Paul A. Reilly, Joanne van Ryn, Oliver Grottke, Stephan Glund, Joachim Stangier. Iconography · @@# @@. Review. Evidence Supporting Idarucizumab ...
Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of...
www.em-consulte.com
· Paul A. Reilly, PhD , Joanne van Ryn, PhD, Oliver Grottke, MD, PhD, Stephan Glund, PhD, Joachim Stangier, PhD. a Clinical Development ...
Ärzte & Mediziner
Idarucizumab jako lek odwracający działanie dabigatranu
www.termedia.pl
— Stephan Glund i wsp. przeanalizowali bezpieczeństwo oraz efektywność wzrastających dawek idarucizumabu, stosowanego celem odwrócenia efektu ... › Idaruciz...
Private Homepages
Dissertations.se: STEPHAN GLUND
www.dissertations.se
Swedish University dissertations (essays) about STEPHAN GLUND. Search and download thousands of Swedish university dissertations. Full text. Free.
‘Toelating antidotum orale antistolling te vroeg’ | medischcontact
www.medischcontact.nl
Ze schreven dat omdat Stephan Glund e.a. middels een placebogecontroleerd fase I-onderzoek bij 47 gezonde mannen het effect van idarucizumab in verschillende doses op de stolling nagingen en primair de veiligheid van het middel beoordeelden. Bij drie deelnemers traden symptomen van ...
LONGUS - Dissertations.se
www.dissertations.se
11. · Robby Zachariah Tom ·; ; 12. · Jan Aydin ·; ; 13. · Stephan Glund ·; AMP-activated protein kinase; interleukin-6; exercise; glucose metabolism; lipid ... › about
Onderzoek naar antidotum NOAC's gaat door | medischcontact
www.medischcontact.nl
— Stephan Glund en zijn collega's van farmaceut Boehringer-Ingelheim publiceren hierover in The Lancet. Zij keken middels een ... › o...
Bücher
The Changing Landscape of Early Medicines Develo
biblio.ugent.be
von T Hardman · · Zitiert von: 1 — Stephan Glund (Boehringer Ingelheim, Germany) discussed how biological agents differ markedly in size and complexity. › publication › file
Authors | Radcliffe Cardiology
www.radcliffecardiology.com
Radcliffe Cardiology article authored by Stephan Glund covering topics in cardiology field
AHA Scientific Sessions 2016: Program Information - American Heart...
books.google.de
The American Heart Association’s Scientific Sessions is bringing big science, big technology, and big networking opportunities to New Orleans, Louisiana...
AHA Scientific Sessions 2016: Program Information
books.google.co.uk
... Boehringer Ingelheim, Ridgefield, CT; Joanne van Ryn, Boehringer Ingelheim, Biberach, Germany; Stephan Glund, Boehringer Ingelheim Pharma GmbH & Co.
Dokumente zum Namen
Medical research slideshare_june_24_2015
www.slideshare.net
MedicalResearch.com features exclusive interviews with medical researchers from major and specialty medical and health care journals and meetings.
BMP4/Gremlin/SMAD Pathway in the Differentiation of Human ...
professional.diabetes.org
SUSANNE SALES, UTA BURO, BRAD HAMILTON, STEPHAN GLUND, STEFAN R. BORNSTEIN, MONIKA EHRHART-BORNSTEIN P Dresden, Germany, Biberach, Germany Human. › a...
OASIS
www.abstractsonline.com
Authors: Stephan Glund, Joachim Stangier, Michael Schmohl, Boehringer Ingelheim GmbH & Co. KG, Biberach an der Riss, Germany; Marina ...
Wissenschaftliche Veröffentlichungen
Idarucizumab for traumatic intracranial hemorrhage during ...
www.jstage.jst.go.jp
9） Stephan Glund, et al: Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male ... › -char
Treatment rapidly reverses the effect of blood thinner dabigatran
www.sciencedaily.com
— Reilly, Joanne van Ryn, John W. Eikelboom, Stephan Glund, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Chak-Wah Kam, ... ›
Veröffentlichungen allgemein
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and...
link.springer.com
Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation. Safety, pharmacokinetics and pharmacodynamics of idaru
APPLIED COURSE INTRODUCTION INTO BASIC AGAH
www.agah.eu
Dr. Stephan Glund. Head of Clinical Pharmacology CREA. Boehringer Ingelheim Pharma GmbH & Co. KG. Biberach (Germany). Dr. Roland Heinig. Stephan Glund, Biberach (Germany). 09:15, Human PK – What's different in biologics? Part 1. An introduction into bioanalytical methods, antibody development ... › wp-content › uploads › AG... › event › aga...
Sonstiges
Idarucizumab, a Specific Reversal Agent for Dabigatran
slideplayer.com
... and Safety and Efficacy in Phase 1 Subjects Paul A. Reilly, PhD, Joanne van Ryn, PhD, Oliver Grottke, MD, PhD, Stephan Glund, PhD, Joachim Stangier, ... › slide
AGAH-Workshop “Introduction into Basic Principles of …
www.bing.com
· Stephan Glund, Biberach (Germany) Break: 10:15 Human PK – What’s different in biologics? Part 2. An introduction into bioanalytical methods, antibody development …
Ansprechpartner im Schuljahr Wieland-Gymnasium …
www.bing.com
7c Thomas Fox / Sabine Schnatz 10c Stephan Glund / Sandra Stopfer Wolfgang Sell 7d Andreas Köhler / Hanno Hohenberger 10d Sandra Traulsen / Monika Wille Holger Rosenbrock …
A dabigatran antikoaguláns hatása gyorsan, hatásosan visszafordítható
www.mkardio.hu
A nem-K vitamin antagonista orális antikoagulánsok hatását visszafordító speciális kezelés nem áll rendelkezésre. Az idarucizumab egy antitest-fragmentum, amit...
NOAK in der praktischen Anwendung – die wichtigsten …
www.bing.com
Stephan Glund S et al. Circulation 2013;128:A Ryn J et al. Thromb Haemost 2010;103:1116– Beyer-Westendorff J et al. Blood 2014;124: Über uns. cme …
AMPK-mediated AS160 phosphorylation in skeletal muscle is ...go.gale.com › i.do
go.gale.com
... Stephan Glund, Atul Deshmukh, Ditte K. Klein, Yun Chau Long, Thomas E. Jensen, . Source: Diabetes. Document Type: Disease/Disorder overview. Abstract :.
Vorlage SOP Allgemein - IAKH
www.bing.com
Stephan Glund, Viktoria Moschetti et al – A randomized study in healthy volunteers to imvestigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to …
A randomised study in healthy volunteers to investigate the ...
facultyopinions.com
1 Dr. Stephan Glund, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany, Tel.: + , Fax: + , ... › article
AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is ...
librarysearch.wlv.ac.uk
... Stephan Glund 2 , Atul Deshmukh 2 , Ditte K. Klein 1 , Yun Chau Long 2 , Thomas E. Jensen 1 , Sebastian B. Jørgensen 1 , Benoit Viollet › ful...
Dr. Paul Reilly, MD – New Kensington, PA | Internal Medicine
www.doximity.com
Stephan Glund, Paul A. Reilly, Joanne van Ryn, Joachim Stangier> ;Clinical Pharmacokinectics Feb 1. Effect of Age and Renal Function on Idarucizumab ...
Antidote Might Reverse Complication From MedicineNet
www.medicinenet.com
... very first clinical study," said the study's lead author, Stephan Glund, a researcher with Boehringer Ingelheim, the drug company that makes Pradaxa. › art
Cardio Notes: Chelation Cuts Cardiac Events | MedPage Today
www.medpagetoday.com
Patients with diabetes -- but not their nondiabetic counterparts -- had lower event rates following chelation therapy. Also, antidotes for the new oral...
British Journal of Clinical Pharmacology
www.bps.ac.uk
... Ippei Ikushima, Wouter Haazen, Akiko Harada, Viktoria Moschetti, Susumu Imazu, Paul A. Reilly, Benjamin Lang, Joachim Stangier, Stephan Glund. › our-journals
Calcineurin regulates skeletal muscle metabolism via SciCrunch
scicrunch.org
Yun Chau Long | Stephan Glund | Pablo M Garcia-Roves | Juleen R Zierath. The Journal of biological chemistry | The metabolic property of skeletal ... › ...
Effect of Age and Renal Function on Idarucizumab Altmetricwww.altmetric.com › details
www.altmetric.com
Stephan Glund, Joachim Stangier, Joanne Ryn, Michael Schmohl, Viktoria Moschetti, Wouter Haazen, Marina Smet, Dietmar Gansser, Stephen Norris, Benjamin ...
Download Figures (PPT) - Journal of Biological Chemistry
www.jbc.org
Yun Chau Long, Stephan Glund, Pablo M. Garcia-Roves, Juleen R. Zierath. Journal of Biological Chemistry. Volume 282 Issue 3 Pages (January 2007). › article › ppt
Download Figures (PPT) - The American Journal of Medicine
www.amjmed.com
Paul A. Reilly, PhD, Joanne van Ryn, PhD, Oliver Grottke, MD, PhD, Stephan Glund, PhD, Joachim Stangier, PhD. The American Journal of Medicine. › article › ppt
Dr. James Aisenberg, MD – New York, NY | Gastroenterology
www.doximity.com
Sake J van der Wall, Renato D. Lopes, James Aisenberg, Paul A. Reilly, Joanne van Ryn, Stephan Glund, Amelie Elsaesser, Frederikus A. Klok, ... › pub
Clinical Pharmacokinetics
www.infona.pl
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Cro… Stephan Glund, Joachim Stangier, Joanne Ryn, Michael Schmohl, more · Clinical Pharmacokinetics > > 56 >
sortiert nach Relevanz / Datum